65 related articles for article (PubMed ID: 23381867)
1. Analysis of protein acetyltransferase structure-function relation by surface-enhanced raman scattering (SERS): a tool to screen and characterize small molecule modulators.
Arif M; Karthigeyan D; Siddhanta S; Kumar GV; Narayana C; Kundu TK
Methods Mol Biol; 2013; 981():239-61. PubMed ID: 23381867
[TBL] [Abstract][Full Text] [Related]
2. Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy.
Arif M; Kumar GV; Narayana C; Kundu TK
J Phys Chem B; 2007 Oct; 111(41):11877-9. PubMed ID: 17894486
[TBL] [Abstract][Full Text] [Related]
3. Activation of p300 histone acetyltransferase by small molecules altering enzyme structure: probed by surface-enhanced Raman spectroscopy.
Mantelingu K; Kishore AH; Balasubramanyam K; Kumar GV; Altaf M; Swamy SN; Selvi R; Das C; Narayana C; Rangappa KS; Kundu TK
J Phys Chem B; 2007 May; 111(17):4527-34. PubMed ID: 17417897
[TBL] [Abstract][Full Text] [Related]
4. Surface-enhanced Raman scattering studies of human transcriptional coactivator p300.
Pavan Kumar GV; Ashok Reddy BA; Arif M; Kundu TK; Narayana C
J Phys Chem B; 2006 Aug; 110(33):16787-92. PubMed ID: 16913819
[TBL] [Abstract][Full Text] [Related]
5. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
6. Ultrasensitive detection and characterization of posttranslational modifications using surface-enhanced Raman spectroscopy.
Sundararajan N; Mao D; Chan S; Koo TW; Su X; Sun L; Zhang J; Sung KB; Yamakawa M; Gafken PR; Randolph T; McLerran D; Feng Z; Berlin AA; Roth MB
Anal Chem; 2006 Jun; 78(11):3543-50. PubMed ID: 16737206
[TBL] [Abstract][Full Text] [Related]
7. K-acetylation and its enzymes: overview and new developments.
Aka JA; Kim GW; Yang XJ
Handb Exp Pharmacol; 2011; 206():1-12. PubMed ID: 21879443
[TBL] [Abstract][Full Text] [Related]
8. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
9. Defining the orphan functions of lysine acetyltransferases.
Montgomery DC; Sorum AW; Meier JL
ACS Chem Biol; 2015 Jan; 10(1):85-94. PubMed ID: 25591746
[TBL] [Abstract][Full Text] [Related]
10. Molecular, cellular, and physiological significance of N-terminal acetylation.
Aksnes H; Hole K; Arnesen T
Int Rev Cell Mol Biol; 2015; 316():267-305. PubMed ID: 25805127
[TBL] [Abstract][Full Text] [Related]
11. Identification of structural features of 2-alkylidene-1,3-dicarbonyl derivatives that induce inhibition and/or activation of histone acetyltransferases KAT3B/p300 and KAT2B/PCAF.
Castellano S; Milite C; Feoli A; Viviano M; Mai A; Novellino E; Tosco A; Sbardella G
ChemMedChem; 2015 Jan; 10(1):144-57. PubMed ID: 25333655
[TBL] [Abstract][Full Text] [Related]
12. Structure of a ternary Naa50p (NAT5/SAN) N-terminal acetyltransferase complex reveals the molecular basis for substrate-specific acetylation.
Liszczak G; Arnesen T; Marmorstein R
J Biol Chem; 2011 Oct; 286(42):37002-10. PubMed ID: 21900231
[TBL] [Abstract][Full Text] [Related]
13. Smad3 is acetylated by p300/CBP to regulate its transactivation activity.
Inoue Y; Itoh Y; Abe K; Okamoto T; Daitoku H; Fukamizu A; Onozaki K; Hayashi H
Oncogene; 2007 Jan; 26(4):500-8. PubMed ID: 16862174
[TBL] [Abstract][Full Text] [Related]
14. Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates.
Furdas SD; Kannan S; Sippl W; Jung M
Arch Pharm (Weinheim); 2012 Jan; 345(1):7-21. PubMed ID: 22234972
[TBL] [Abstract][Full Text] [Related]
15. Assessing acetylation of NF-kappaB.
Chen LF; Greene WC
Methods; 2005 Aug; 36(4):368-75. PubMed ID: 16111893
[TBL] [Abstract][Full Text] [Related]
16. Interaction between acetylated MyoD and the bromodomain of CBP and/or p300.
Polesskaya A; Naguibneva I; Duquet A; Bengal E; Robin P; Harel-Bellan A
Mol Cell Biol; 2001 Aug; 21(16):5312-20. PubMed ID: 11463815
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of p300-HAT alters global gene expression and represses HIV replication.
Mantelingu K; Reddy BA; Swaminathan V; Kishore AH; Siddappa NB; Kumar GV; Nagashankar G; Natesh N; Roy S; Sadhale PP; Ranga U; Narayana C; Kundu TK
Chem Biol; 2007 Jun; 14(6):645-57. PubMed ID: 17584612
[TBL] [Abstract][Full Text] [Related]
18. Acetylation of HIV-1 integrase by p300 regulates viral integration.
Cereseto A; Manganaro L; Gutierrez MI; Terreni M; Fittipaldi A; Lusic M; Marcello A; Giacca M
EMBO J; 2005 Sep; 24(17):3070-81. PubMed ID: 16096645
[TBL] [Abstract][Full Text] [Related]
19. Reversible acetylation of non histone proteins: role in cellular function and disease.
Batta K; Das C; Gadad S; Shandilya J; Kundu TK
Subcell Biochem; 2007; 41():193-212. PubMed ID: 17484129
[TBL] [Abstract][Full Text] [Related]
20. Analysis of p300 acetyltransferase substrate specificity by MALDI TOF mass spectrometry.
Dormeyer W; Ott M; Schnölzer M
Methods; 2005 Aug; 36(4):376-82. PubMed ID: 16085422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
